Business Daily Media

The Times Real Estate

.

AIM Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S.

Multiple Institutions Give AIM a "Buy" Rating

HONG KONG SAR - Media OutReach Newswire – 5 February 2025 - AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to the U.S.

Food and Drug Administration (FDA). The vaccine has demonstrated significantly higher humoral and cellular immunity compared to internationally marketed products. If the product progresses smoothly, it will accelerate AIM Vaccine's international expansion and contribute to substantial performance growth.

In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly higher levels of specific IgG antibody titers, live-virus neutralizing antibody potency, and specific T-cell immunity compared to internationally marketed mRNA RSV control vaccines.

This announcement highlights AIM Vaccine's innovative capabilities and underscores the acceleration of its internationalization efforts, which have been recognized by multiple institutions.

Recently, FOSUN INTERNATIONAL SECURITIES initiated coverage of AIM Vaccine, assigning a "Buy" rating with a 12-month target price of HKD 11.0. The report cited the company's strong product pipeline, technological leadership, and potential for international growth as key factors. Similarly, SDICSI released a research report predicting that AIM Vaccine will launch 1-2 products annually over the next three years. If the products in development gain approval and progress smoothly in international markets, they are expected to drive new performance growth and expand market potential. SDICSI also assigned a "Buy" rating with a target price of HKD 9.5.

FOSUN INTERNATIONAL SECURITIES's analysis indicates that the Chinese vaccine market is evolving in line with global trends, where high-value products and leading companies dominate. With its differentiated advantages, AIM Vaccine is poised to secure a leading position in the domestic market while achieving scalable expansion internationally. Additionally, the company's comprehensive and iterative product portfolio is expected to enhance its market share, pricing power, and profitability, further supporting long-term growth.

The report also emphasized that AIM Vaccine, with its diversified product portfolio, technological strengths, and global expansion strategy, presents an attractive investment opportunity for investors. With a series of high-value products set to launch and profitability expected to rebound from 2025 onwards, the company is positioned for strong growth and potential valuation reassessment.

Globally, there are currently no approved antiviral drugs for RSV available for clinical use. Vaccination for active immune prophylaxis remains the most effective means to prevent severe RSV infections. No RSV vaccines have been approved for marketing in PRC. In 2023, global sales of RSV vaccines reached USD 2.46 billion, and according to industry consultants, the market size is expected to grow to approximately USD 16.7 billion by 2030.

The mRNA vaccine field is still wide open with plenty of opportunities, as there are few competitors globally. AIM Vaccine is one of the earliest companies in PRC to develop mRNA vaccine products and is among the first domestic vaccine enterprises to obtain independent patents for mRNA technology. The company has established a mature mRNA vaccine R&D system and has developed multiple mRNA candidate vaccines, including vaccines for shingles, rabies, and influenza, in addition to the mRNA RSV vaccine.
Hashtag: #AIMVaccine

The issuer is solely responsible for the content of this announcement.

News from Asia

Promotional Event of CIFTIS Successfully Held in Singapore

SINGAPORE - Media OutReach Newswire - 24 April 2025 - On April 23rd, a promotional event organized by a delegation from the China International Fair for Trade in Services (CIFTIS) was successfully...

Claim Your Golden Delights With DFS

Indulge in Extraordinary Rewards & Experiences This May Golden Week HONG KONG SAR - Media OutReach Newswire - 24 April 2025 - This May Golden Week, let DFS —the world's leading luxury travel r...

Disney’s 20th Anniversary: HKDL Ambassadors Prepare to Pass the Torch

Seeking the Next Ambassador to Continue the Mission of Spreading Magic and Helping Others HONG KONG SAR - Media OutReach Newswire - 25 April 2025 - Hong Kong Disneyland Resort (HKDL) has bee...

Hong Kong’s Visionaries Invited to Lead the Conversation at ACES Awards 2025

Wave 2 Nominations Now Open HONG KONG SAR- Media OutReach Newswire - 25 April 2025 – In a city built on precision, resilience and reinvention, Hong Kong's corporate leadership is entering a new er...

Smartcom Expands into Indonesia to Strengthen Regional PTT Communications

SINGAPORE - Media OutReach Newswire - 25 April 2025 - Smartcom, a Mobile Virtual Network Operator (MVNO) in Singapore, is expanding its reach beyond the city-state into Indonesia. This initiative ...

Democracy News Alliance - Australia’s next government must mend structural cracks appearing in its political, economic and social foundation, report finds

LOS ANGELES, US - Newsaktuell - 25 April 2025 - Australia boasts some of the world's most sophisticated political institutions and one of its wealthiest economies. But this veneer of success mas...

ASUS and JustCo Launch New Experience Zones in Singapore

Business travelers and modern workers can now enjoy ASUS monitors, ergonomic chairs and more at JustCo locations in Changi Airport T3 and International Plaza Expanded partnership: ASUS and...

Super March Success: MDRi's Insights into Hong Kong's Mega Event Momentum

Reflecting the vibrancy of Hong Kong’s cultural identity and reinforcing its standing as a premier destination for global events A significant 55% of respondents were aware of the Super Ma...

Ascott’s Multi-typology Strategy Fuels Expansion In Asia, Africa And The Middle East, Surpassing 17,400 Ascott-branded Units

SINGAPORE - Media OutReach Newswire - 25 April 2025 - The Ascott Limited (Ascott), the wholly owned lodging business unit of CapitaLand Investment (CLI), is accelerating the global growth of its e...

GE Jun’s "Grain Rain Speech" Ignites Chengdu: A Bold Vision for China’s Private Sector on the Global Stage

HONG KONG SAR - Media OutReach Newswire - 25 April 2025 - In an atmosphere charged anticipation and entrepreneurial urgency, GE Jun, Chairman and CEO of TOJOY Smart Enterprise Services, delivered ...

Businesses losing an average of $493k from data integrity flaws

Managing data responsibly and effectively for the AI age can give organisations a strong competitive advantage, but many are failing to harness th...

AI shopping disruptor Zyft raises $7.5M to lead the next gen of retail tech

Zyft appoints new CEO, Richard Stevens, to lead the latest Waller Group success story, valued at $30 million SYDNEY, 28 April 2025: Zyft, the lea...

Little known law offers savvy Kiwis the opportunity to supercharge their retirement savings

A little-known legal amendment is being leveraged by savvy New Zealanders and expat Brits to supercharge their retirement savings. Not many peop...

Cutting edge AI technology designed for doctors to reduce patient wait times launched in NZ

New Zealand specialist doctors now have access to Artificial Intelligence technology to help reduce patient wait times and experts say it could be...

Launchd Takes Off: Former AFL Stars Lead Tech-Powered Platform Set to Disrupt Talent and Influencer Marketing

Backed by Institutional Capital, Launchd Combines Five Leading Agencies and Smart Technology to Deliver Measurable Results Influencer marketing i...

Meet the Australian fintech unlocking rewards for small businesses

Small businesses make up 98 per cent of all businesses in Australia, yet they continue to bear the brunt of economic uncertainty. According to Credi...

Sell by LayBy